RBC Bioscience

RBC Bioscience Deferred Tax Liabilities

The Deferred Tax Liabilities of RBC Bioscience (6848.TWO) as of Nov 6, 2026 is 34,000.00 TWD. In the previous year, Deferred Tax Liabilities was 34,000.00 TWD — a change of 0.00% (lower).

Deferred Tax Liabilities

34,000.00TWD

YoY

0.00%

Last updated:

Deferred Tax Liabilities of RBC Bioscience is 2019 34,000.00 TWD. Deferred Tax Liabilities of RBC Bioscience was 2018 34,000.00 TWD. It decreases by 0.00% lower compared to the previous year.

The RBC Bioscience Deferred Tax Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Deferred Tax Liabilities
Date
Deferred Tax Liabilities
Jan 1, 2018
34,000.00 TWD
Jan 1, 2019
34,000.00 TWD
The RBC Bioscience Deferred Tax Liabilities history
YEARDeferred Tax LiabilitiesYoY
34,000.00TWD0.00%
34,000.00TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp manufactures reagents and devices for life science and molecular diagnosis. The company's products include instruments equipped with ultraviolet sterilization systems for nucleic acid purification and disposable reagent strips and tips that work with built-in control programs for different nucleic acid extraction types. The firm developed nucleic acid purification reagents with cellulose-embedded magnetic beads to improve DNA and RNA purity for blood, bacteria, viruses, and forensic examinations. These products are used for future diagnosis, prevention, tracking, and treatment of diseases. The company sells its instruments and reagents to customers in life science and molecular diagnosis sectors. The instruments feature ultraviolet sterilization systems, while the reagents include disposable strips and tips with varying control programs. The reagents with cellulose-embedded magnetic beads are designed for high-purity nucleic acid extraction from diverse samples including blood, bacteria, viruses, and forensic materials. RBC Bioscience Corp's revenue comes from the sale of instruments and reagents. The instruments are sold to laboratories and medical facilities requiring nucleic acid purification systems. The reagents, including the disposable strips and tips, are sold alongside the instruments or separately for ongoing use in molecular diagnosis processes. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

Deferred Tax Liabilities of RBC Bioscience is 34,000.00 TWD in 2019.

Deferred Tax Liabilities of RBC Bioscience changed from 34,000.00 TWD to 34,000.00 TWD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — RBC Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — RBC Bioscience